PRECOSE® is therapeutically desired. Following oral dosing of healthy volunteers with 14C-labeled acarbose, peak plasma concentrations of radioactivity were (acarbose tablets) attained 14–24 hours after dosing, while

First Page		Document Content
Date: 2011-08-04 09:47:10 Endocrinology Anti-diabetic medication Acarbose Alpha-glucosidase inhibitor Hypoglycemia Diabetes management Metformin Sulfonylurea Insulin therapy Diabetes Endocrine system Medicine		PRECOSE® is therapeutically desired. Following oral dosing of healthy volunteers with 14C-labeled acarbose, peak plasma concentrations of radioactivity were (acarbose tablets) attained 14–24 hours after dosing, while Add to Reading List Source URL: www.univgraph.com Download Document from Source Website File Size: 145,04 KB Share Document on Facebook

	North Shore Hematology / Oncology Associates, P.C. Conquering Cancer… Close to Home™ The following information is mandatory and of g DocID: 1pCOH - View Document
	Camillo Ricordi Director, Diabetes Research Institute and Cell transplant Program, University of Miami Synopsis of area of interest: Development of cell therapy technologies and tolerance induction strategies for DocID: 1kLKg - View Document
	Practical aspects of large register studies: Multiple states and multiple timescales: The diabetes and cancer study. Bendix Carstensen Senior Statistician, Steno Diabetes Center, Denmark DocID: 1gtMJ - View Document
	Emerging Treatments and Technologies O R I G I N A L A R T I C L E Implementation of a Safe and Effective DocID: 1ggrg - View Document
	Artificial pancreas device systems in development for the closed-loop control of type 1 diabetes DocID: 1fBJy - View Document